FIELD: medicine.
SUBSTANCE: invention represents a pharmaceutical composition for treating the HIV infection in the form of a solid dosage form, containing at least one HIV protease inhibitor in a therapeutically effective amount specified in a group of nelfinavir, sacvinavir, tipranavir, darunavir, indinavir, ritonavir, lopinavir, palinavir or fosamprenavir, and pharmaceutically acceptable additives differing by the fact that as the pharmaceutically acceptable additives it contains at least one water-insoluble polymer from 0.39 to 28 wt % of the total dosage form, surfactants, excipients up to 100% of the total dosage form, as well as a method of treating the HIV infection.
EFFECT: pharmaceutical composition according to the invention possesses the improved technological properties and improved bioavailability as compared to a prototype therapeutic agent.
10 cl, 4 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FOR TREATING HIV INFECTION, METHOD FOR PREPARING IT, AND METHOD OF TREATING | 2012 |
|
RU2505286C1 |
| PHARMACEUTICAL COMPOSITION FOR HIV INFECTION TREATMENT | 2016 |
|
RU2619840C1 |
| PHARMACEUTICAL COMPOSITION HAVING ANTI-HIV INFECTION ACTIVITY | 2017 |
|
RU2659693C1 |
| SOLID PHARMACEUTICAL COMPOSITION FOR MANUFACTURING ORAL ANTIRETROVIRAL THERAPEUTIC AGENT | 2020 |
|
RU2760129C1 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING ANTIRETROVIRAL DRUG AND PHARMACOKINETICS IMPROVER | 2017 |
|
RU2745204C2 |
| PHARMACEUTICALLY ACCEPTABLE SOLUBILISING COMPOSITION AND PHARMACEUTICAL DOSAGE FORM CONTAINING IT | 2007 |
|
RU2469708C2 |
| SOLID PHARMACEUTICAL COMPOSITION FOR MANUFACTURE OF ORAL THERAPEUTIC AGENT FOR PREVENTION AND/OR TREATMENT OF HIV INFECTION | 2021 |
|
RU2759544C1 |
| METHOD FOR APPLICATION OF COPOLYMER OF DIMETHYLAMINOETHYLMETHACRYLATE, BUTYLMETHACRYLATE AND METHYL METHACRYLATE TO INCREASE SOLUBILITY AND/OR BIOAVAILABILITY OF ANTIRETROVIRAL ACTIVE PHARMACEUTICAL SUBSTANCE IN MANUFACTURE OF SOLID DISPERSION ON GRANULAR CARRIER | 2020 |
|
RU2759547C1 |
| COMPOSITION FOR PREVENTION AND / OR TREATMENT OF HIV INFECTION | 2017 |
|
RU2663466C1 |
| METHODS FOR IMPROVING PHARMACOKINETICS | 2010 |
|
RU2591830C2 |
